Overexpression of transforming growth factor ?-type II receptor reduces tumorigenicity and metastastic potential of K-ras-transformed thyroid cells
Open Access
- 5 January 1999
- journal article
- Published by Wiley in International Journal of Cancer
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Restored expression of transforming growth factor β type II receptor ink-ras-transformed thyroid cells, TGFβ-resistant, reverts their malignant phenotypeJournal of Cellular Physiology, 1997
- Partnership between DPC4 and SMAD proteins in TGF-β signalling pathwaysNature, 1996
- Tumor suppressor activity of the TGF-β pathway in human cancersCytokine & Growth Factor Reviews, 1996
- Loss of responsiveness to transforming growth factor β (TGFβ) is tightly linked to tumorigenicity in a model of thyroid tumour progressionInternational Journal of Cancer, 1996
- Inactivation of the Type II TGF-β Receptor in Colon Cancer Cells with Microsatellite InstabilityScience, 1995
- Genetic changes in the transforming growth factor beta (TGF-beta) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-beta.Proceedings of the National Academy of Sciences, 1994
- The TGF-β family and its composite receptorsTrends in Cell Biology, 1994
- Growth inhibition by transforming growth factor beta (TGF-beta) type I is restored in TGF-beta-resistant hepatoma cells after expression of TGF-beta receptor type II cDNA.Proceedings of the National Academy of Sciences, 1993
- TGFβ induction of extracellular matrix associated proteins in normal and transformed human mammary epithelial cells in culture is independent of growth effectsJournal of Cellular Physiology, 1993
- Effects of Transforming Growth Factor-β on Deoxyribonucleic Acid Synthesis and Iodine Metabolism in Porcine Thyroid Cells in Culture*Endocrinology, 1988